Penghong Song

2.5k total citations
66 papers, 1.7k citations indexed

About

Penghong Song is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Penghong Song has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 24 papers in Oncology and 19 papers in Surgery. Recurrent topics in Penghong Song's work include Ion Transport and Channel Regulation (12 papers), Ion channel regulation and function (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Penghong Song is often cited by papers focused on Ion Transport and Channel Regulation (12 papers), Ion channel regulation and function (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Penghong Song collaborates with scholars based in China, Madagascar and Germany. Penghong Song's co-authors include Haiyang Xie, Shusen Zheng, Xiao Xu, Lin Zhou, Ursula Seidler, Brigitte Riederer, Wenfeng Song, Shusen Zheng, Hangxiang Wang and Zefeng Xuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Penghong Song

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Penghong Song China 23 1.0k 301 250 229 229 66 1.7k
Masoud Darabi Iran 24 617 0.6× 199 0.7× 267 1.1× 137 0.6× 284 1.2× 108 1.8k
Jie Gao China 24 910 0.9× 251 0.8× 109 0.4× 164 0.7× 296 1.3× 90 1.7k
Xuan Sun China 22 1.5k 1.5× 191 0.6× 303 1.2× 126 0.6× 519 2.3× 76 2.4k
Yue Wu China 29 1.0k 1.0× 257 0.9× 119 0.5× 176 0.8× 428 1.9× 110 2.3k
Leyuan Xu United States 26 615 0.6× 156 0.5× 357 1.4× 181 0.8× 102 0.4× 36 1.4k
Amalia Luce Italy 18 585 0.6× 252 0.8× 113 0.5× 109 0.5× 303 1.3× 42 1.2k
Xiao‐Han Tang China 21 1.1k 1.1× 321 1.1× 268 1.1× 111 0.5× 250 1.1× 93 2.2k
Yan Luo China 15 727 0.7× 552 1.8× 154 0.6× 95 0.4× 131 0.6× 44 1.4k

Countries citing papers authored by Penghong Song

Since Specialization
Citations

This map shows the geographic impact of Penghong Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penghong Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penghong Song more than expected).

Fields of papers citing papers by Penghong Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penghong Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penghong Song. The network helps show where Penghong Song may publish in the future.

Co-authorship network of co-authors of Penghong Song

This figure shows the co-authorship network connecting the top 25 collaborators of Penghong Song. A scholar is included among the top collaborators of Penghong Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penghong Song. Penghong Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Danrui, Xiaoyu Chen, Wenfeng Song, et al.. (2025). The FBXW7‐RPAP2 Axis Controls the Growth of Hepatocellular Carcinoma Cells and Determines the Fate of Liver Cell Differentiation. Advanced Science. 12(13). e2404718–e2404718. 3 indexed citations
2.
Zhang, Shiyu, Haojiang Dai, Wenfeng Song, et al.. (2024). SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation. Cancer Communications. 44(3). 384–407. 22 indexed citations
3.
Yang, Zhentao, Haiyang Xie, Jianqin Wan, et al.. (2023). A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation. EBioMedicine. 92. 104594–104594. 4 indexed citations
4.
Wang, Ning, Ke Zhou, Ruiqi Sun, et al.. (2023). RapaLink-1 outperforms rapamycin in alleviating allogeneic graft rejection by inhibiting the mTORC1-4E-BP1 pathway in mice. International Immunopharmacology. 125(Pt B). 111172–111172. 6 indexed citations
5.
Song, Guangyuan, Xiaoyi Hu, Hai Zhu, et al.. (2022). Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3. Cancer Research. 82(21). 3987–4000. 20 indexed citations
6.
Li, Zequn, Guangyuan Song, Wenfeng Song, et al.. (2022). Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening. Bioactive Materials. 18. 164–177. 32 indexed citations
7.
Chen, Jian, Zequn Li, Wenfeng Song, et al.. (2021). Targeting WEE1 by adavosertib inhibits the malignant phenotypes of hepatocellular carcinoma. Biochemical Pharmacology. 188. 114494–114494. 12 indexed citations
8.
Wei, Qiang, Kun Wang, Modan Yang, et al.. (2020). Recipient gender and body mass index are associated with early acute rejection in donation after cardiac death liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 44. 100004–100004. 3 indexed citations
9.
Chen, Hao, Jun Chen, Long Zhao, et al.. (2019). CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma. Journal of Cancer. 10(8). 1846–1854. 47 indexed citations
10.
Chen, Jun, Zequn Li, Jian Chen, et al.. (2019). Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21. Clinical & Translational Oncology. 22(3). 392–400. 12 indexed citations
11.
Xuan, Zefeng, Jian Chen, Penghong Song, et al.. (2018). Management of intrahepatic splenosis:a case report and review of the literature. World Journal of Surgical Oncology. 16(1). 119–119. 14 indexed citations
12.
Wang, Hangxiang, Zhongjie Lu, Lijiang Wang, et al.. (2017). New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity. Cancer Research. 77(24). 6963–6974. 133 indexed citations
13.
Ling, Sunbin, Jie Li, Qiaonan Shan, et al.. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Molecular Oncology. 11(6). 682–695. 84 indexed citations
14.
Song, Penghong, Wenfeng Song, Hao Chen, et al.. (2017). KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma. Journal of Cancer. 8(9). 1568–1578. 17 indexed citations
15.
Chen, Hao, Zefeng Xuan, Wenfeng Song, et al.. (2016). Bile deficiency induces changes in intestinal glucose absorption in mice. Surgery. 160(6). 1496–1507. 6 indexed citations
16.
Li, Zhiwei, Fei Sun, Yaohui Zhang, et al.. (2015). Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. PLoS ONE. 10(11). e0143405–e0143405. 34 indexed citations
17.
Ding, Songming, Wu Zhang, Zhiyuan Xu, et al.. (2013). Induction of an EMT-like transformation and MET in vitro. Journal of Translational Medicine. 11(1). 164–164. 18 indexed citations
19.
Xu, Jie, Penghong Song, Suguru Nakamura, et al.. (2009). Deletion of the Chloride Transporter Slc26a7 Causes Distal Renal Tubular Acidosis and Impairs Gastric Acid Secretion. Journal of Biological Chemistry. 284(43). 29470–29479. 81 indexed citations
20.
Xu, Jie, Penghong Song, Marian L. Miller, et al.. (2008). Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach. Proceedings of the National Academy of Sciences. 105(46). 17955–17960. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026